Found: 29
Select item for more details and to access through your institution.
Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.768957
- By:
- Publication type:
- Article
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 1, p. 573, doi. 10.1245/s10434-022-12600-2
- By:
- Publication type:
- Article
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 12, p. 3945, doi. 10.1245/s10434-019-07274-2
- By:
- Publication type:
- Article
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3123, doi. 10.1007/s00262-021-02871-1
- By:
- Publication type:
- Article
Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2656, doi. 10.3390/cancers16152656
- By:
- Publication type:
- Article
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2922, doi. 10.3390/cancers15112922
- By:
- Publication type:
- Article
Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 409, doi. 10.3390/cancers15020409
- By:
- Publication type:
- Article
Systemic Therapy in Advanced Nodular Melanoma versus Superficial Spreading Melanoma: A Nation-Wide Study of the Dutch Melanoma Treatment Registry.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5694, doi. 10.3390/cancers14225694
- By:
- Publication type:
- Article
Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5077, doi. 10.3390/cancers13205077
- By:
- Publication type:
- Article
Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort Study.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4639, doi. 10.3390/cancers13184639
- By:
- Publication type:
- Article
Plasma BRAF Mutation Detection for the Diagnostic and Monitoring Trajectory of Patients with LDH-High Stage IV Melanoma.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3913, doi. 10.3390/cancers13153913
- By:
- Publication type:
- Article
Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint Inhibitors †.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2826, doi. 10.3390/cancers13112826
- By:
- Publication type:
- Article
Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2072, doi. 10.3390/cancers12082072
- By:
- Publication type:
- Article
Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1176, doi. 10.3390/cancers12051176
- By:
- Publication type:
- Article
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Adjuvant treatment with anti‐PD‐1 in acral melanoma: A nationwide study.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 8, p. 1455, doi. 10.1002/ijc.35060
- By:
- Publication type:
- Article
Adjuvant treatment of in‐transit melanoma: Narrowing the knowledge gap left by clinical trials.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 2, p. 389, doi. 10.1002/ijc.34485
- By:
- Publication type:
- Article
The unfavorable effects of COVID‐19 on Dutch advanced melanoma care.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 5, p. 816, doi. 10.1002/ijc.33833
- By:
- Publication type:
- Article
Tyrosine Kinase Inhibitor Sorafenib Decreases <sup>111</sup>In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 2, p. 242, doi. 10.2967/jnumed.113.131110
- By:
- Publication type:
- Article
Correlation of toxicity and efficacy with pharmacokinetics (PK) of pegylated liposomal doxorubicin (PLD) (Caelyx((R)))
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Long-Term Survival in Patients With Advanced Melanoma.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2426641, doi. 10.1001/jamanetworkopen.2024.26641
- By:
- Publication type:
- Article
Real‐world outcomes of advanced melanoma patients not represented in phase III trials.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 12, p. 3461, doi. 10.1002/ijc.33162
- By:
- Publication type:
- Article
Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Endoscopy in patients with diarrhea during treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors: Is the cause in the mucosa?
- Published in:
- Acta Oncologica, 2016, v. 55, n. 4, p. 444, doi. 10.3109/0284186X.2015.1119883
- By:
- Publication type:
- Article
BRAF/MEK inhibitor rechallenge in advanced melanoma patients.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1673, doi. 10.1002/cncr.35178
- By:
- Publication type:
- Article